TAM
YMAB

Tyers Asset Management’s Y-mAbs Therapeutics YMAB Stock Holding History

Tyers Asset Management’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$39K Sell
1,484
-560
-27% -$14.3K ﹤0.01% 927
2019
Q2 		$47K Sell
2,044
-1,400
-41% -$32.2K ﹤0.01% 933
2019
Q1 		$90K Hold
3,444
– – ﹤0.01% 854
2018
Q4 		$70K Sell
3,444
-3,864
-53% -$88.7K ﹤0.01% 851
2018
Q3 		$194K Buy
+7,308
New +$186K 0.01% 756

Other funds holding YMAB

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Tyers Asset Management's YMAB Position: Q3 2019 in Review

Tyers Asset Management reduced its Y-mAbs Therapeutics (YMAB) stake by 27% in Q3 2019, selling an estimated $14.3K and leaving 1,484 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #927.

Tyers Asset Management first reported a position in YMAB in Q3 2018 and has held it in 5 quarters since. The position peaked at $194K in Q3 2018. 65 funds tracked by Wall St. Rank hold YMAB as of Q3 2019.

  • Tyers Asset Management held 1,484 shares of Y-mAbs Therapeutics worth $39K as of Q3 2019.
  • Tyers Asset Management sold 560 Y-mAbs Therapeutics shares in Q3 2019, an estimated $14.3K.
  • Y-mAbs Therapeutics made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #927 holding.
  • Tyers Asset Management first reported a position in Y-mAbs Therapeutics in Q3 2018 and has held it in 5 quarters since.
  • Tyers Asset Management's Y-mAbs Therapeutics position peaked at $194K in Q3 2018.
  • 65 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.